Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| INJESTA SOFT CAPSULE 200MG | GOLDPLUS UNIVERSAL PTE LTD | INJESTA SOFT CAPSULE 200MG | Nov 7, 2025 | SIN17386P |
| NUVAXOVID DISPERSION FOR INJECTION COVID19 VACCINE 5MCG/DOSE (RECOMBINANT, ADJUVANTED) IN PFS | SANOFI-AVENTIS SINGAPORE PTE. LTD. | NUVAXOVID DISPERSION FOR INJECTION COVID19 VACCINE 5MCG/DOSE (RECOMBINANT, ADJUVANTED) IN PFS | Nov 4, 2025 | SIN17384P |
| LUTETIUM (177LU) CHLORIDE RADIOPHARMACEUTICAL PRECURSOR SOLUTION 51.8 GBQ/ML | TRANSMEDIC PTE LTD | LUTETIUM (177LU) CHLORIDE RADIOPHARMACEUTICAL PRECURSOR SOLUTION 51.8 GBQ/ML | Nov 3, 2025 | SIN17383P |
| ADLARITY TRANSDERMAL SYSTEM 5 mg/24 hours | LOTUS INTERNATIONAL PTE. LTD. | ADLARITY TRANSDERMAL SYSTEM 5 mg/24 hours | Nov 3, 2025 | SIN17381P |
| ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours | LOTUS INTERNATIONAL PTE. LTD. | ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours | Nov 3, 2025 | SIN17382P |
| SCIOTIDE LAI POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 20MG/VIAL | SCIGEN PTE. LTD. | SCIOTIDE LAI POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 20MG/VIAL | Oct 31, 2025 | SIN17380P |
| SCIOTIDE LAI POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 30MG/VIAL | SCIGEN PTE. LTD. | SCIOTIDE LAI POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 30MG/VIAL | Oct 31, 2025 | SIN17379P |
| AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL | FRESENIUS KABI (SINGAPORE) PTE LTD | AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL | Oct 30, 2025 | SIN17378P |
| AUDENZ® PANDEMIC INFLUENZA VACCINE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE | SEQIRUS PTE. LTD. | AUDENZ® PANDEMIC INFLUENZA VACCINE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE | Oct 29, 2025 | SIN17377P |
| PREGABALIN-AFT CAPSULES 75MG | APEX PHARMA MARKETING PTE. LTD. | PREGABALIN-AFT CAPSULES 75MG | Oct 27, 2025 | SIN17376P |
| LEAVDO CAPSULE 25MG | PHARM-D SINGAPORE PRIVATE LIMITED | LEAVDO CAPSULE 25MG | Oct 24, 2025 | SIN17375P |
| LEAVDO CAPSULE 15MG | PHARM-D SINGAPORE PRIVATE LIMITED | LEAVDO CAPSULE 15MG | Oct 24, 2025 | SIN17374P |
| LEAVDO CAPSULE 10MG | PHARM-D SINGAPORE PRIVATE LIMITED | LEAVDO CAPSULE 10MG | Oct 24, 2025 | SIN17373P |
| AXITINIB SANDOZ FILM COATED TABLET 5 MG | SANDOZ SINGAPORE PTE. LTD. | AXITINIB SANDOZ FILM COATED TABLET 5 MG | Oct 23, 2025 | SIN17370P |
| LEAVDO CAPSULE 5MG | PHARM-D SINGAPORE PRIVATE LIMITED | LEAVDO CAPSULE 5MG | Oct 23, 2025 | SIN17372P |
| AXITINIB SANDOZ FILM COATED TABLET 1 MG | SANDOZ SINGAPORE PTE. LTD. | AXITINIB SANDOZ FILM COATED TABLET 1 MG | Oct 23, 2025 | SIN17371P |
| XTANDI™ FILM-COATED TABLETS 40MG | ASTELLAS PHARMA SINGAPORE PTE. LTD. | XTANDI™ FILM-COATED TABLETS 40MG | Oct 21, 2025 | SIN17368P |
| TAZATRED DASATINIB TABLETS 20MG | EURO ASIA MEDICO PTE. LTD. | TAZATRED DASATINIB TABLETS 20MG | Oct 21, 2025 | SIN17367P |
| TAZATRED DASATINIB TABLETS 70MG | EURO ASIA MEDICO PTE. LTD. | TAZATRED DASATINIB TABLETS 70MG | Oct 21, 2025 | SIN17365P |
| TAZATRED DASATINIB TABLETS 50MG | EURO ASIA MEDICO PTE. LTD. | TAZATRED DASATINIB TABLETS 50MG | Oct 21, 2025 | SIN17366P |
